Beherasco, Aida F.

HRN: 21-30-45  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2022
CEFUROXIME 750MG (VIAL)
05/07/2022
05/08/2022
IV
750mg
3 Doses
S/P TAHBSO
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Skin & Soft TissueIntra-abdominal    Compliance to guidelines: Guideline Not Available

Initial appropriateness: Yes   

Final appropriateness: No  Wrong Dose  Wrong Dose

Overall appropriateness: No  Wrong Dose

Intervention



Type of Intervention done:

                    

           


Acceptance: